322 related articles for article (PubMed ID: 23046417)
21. Long term cryopreservation in 5% DMSO maintains unchanged CD34(+) cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation.
Abbruzzese L; Agostini F; Durante C; Toffola RT; Rupolo M; Rossi FM; Lleshi A; Zanolin S; Michieli M; Mazzucato M
Vox Sang; 2013 Jul; 105(1):77-80. PubMed ID: 23384290
[TBL] [Abstract][Full Text] [Related]
22. Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxide.
Trummer T; Fox R; Koç JR; de Lima M; Otegbeye F
Cytotherapy; 2020 Nov; 22(11):613-616. PubMed ID: 32600975
[TBL] [Abstract][Full Text] [Related]
23. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
[TBL] [Abstract][Full Text] [Related]
24. Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve.
Tijssen MR; Woelders H; de Vries-van Rossen A; van der Schoot CE; Voermans C; Lagerberg JW
Transfusion; 2008 May; 48(5):893-901. PubMed ID: 18298597
[TBL] [Abstract][Full Text] [Related]
25. Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant.
Galmés A; Besalduch J; Bargay J; Novo A; Morey M; Guerra JM; Duran MA
Transfusion; 1999 Jan; 39(1):70-3. PubMed ID: 9920169
[TBL] [Abstract][Full Text] [Related]
26. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO.
Lakota J; Fuchsberger P
Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035
[No Abstract] [Full Text] [Related]
27. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
[TBL] [Abstract][Full Text] [Related]
28. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
Vrhovac R; Perić Z; Jurenec S; Kardum-Skelin I; Jelić-Puskarić B; Jaksić B
Coll Antropol; 2010 Mar; 34(1):163-9. PubMed ID: 20432746
[TBL] [Abstract][Full Text] [Related]
29. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
[TBL] [Abstract][Full Text] [Related]
30. Optimal cryopreservation of human umbilical cord blood.
Donaldson C; Armitage WJ; Denning-Kendall PA; Nicol AJ; Bradley BA; Hows JM
Bone Marrow Transplant; 1996 Oct; 18(4):725-31. PubMed ID: 8899187
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
Rodríguez L; Velasco B; García J; Martín-Henao GA
Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
[TBL] [Abstract][Full Text] [Related]
32. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide.
Abrahamsen JF; Rusten L; Bakken AM; Bruserud Ø
Transfusion; 2004 May; 44(5):785-9. PubMed ID: 15104663
[TBL] [Abstract][Full Text] [Related]
33. Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB.
Stylianou J; Vowels M; Hadfield K
Cytotherapy; 2006; 8(1):57-61. PubMed ID: 16627345
[TBL] [Abstract][Full Text] [Related]
34. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
[TBL] [Abstract][Full Text] [Related]
35. Leukapheresis cell concentration adjustment required for a successful recovery of HSC after cryopreservation.
Mohammed RN; Ahmad D; Khoshnaw N; Hassan DO; Abdulrahman HA; Vacca M; Possenti M; Faruq D; Omer H; Muhamad S; Majolino I; Othman DN
Cryobiology; 2020 Feb; 92():21-25. PubMed ID: 31563591
[TBL] [Abstract][Full Text] [Related]
36. Low-molecular-weight carbohydrate Pentaisomaltose may replace dimethyl sulfoxide as a safer cryoprotectant for cryopreservation of peripheral blood stem cells.
Svalgaard JD; Haastrup EK; Reckzeh K; Holst B; Glovinski PV; Gørløv JS; Hansen MB; Moench KT; Clausen C; Fischer-Nielsen A
Transfusion; 2016 May; 56(5):1088-95. PubMed ID: 26991781
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases.
Hernández-Navarro F; Ojeda E; Arrieta R; Ríos-Rull P; García-Bustos J; Quevedo E; Martín Hernández MP; Jiménez-Yuste V; Rodríguez-Luaces M; López RM; García-Miguel P; Martínez A; Sastre A; Calero F; Gómez-Pastrana F; Martínez B
Bone Marrow Transplant; 1998 Mar; 21(5):511-7. PubMed ID: 9535044
[TBL] [Abstract][Full Text] [Related]
38. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells.
Scheinkönig C; Kappicht S; Kolb HJ; Schleuning M
Bone Marrow Transplant; 2004 Sep; 34(6):531-6. PubMed ID: 15286692
[TBL] [Abstract][Full Text] [Related]
39. Optimization of the freezing process for hematopoietic progenitor cells: effect of precooling, initial dimethyl sulfoxide concentration, freezing program, and storage in vapor-phase or liquid nitrogen on in vitro white blood cell quality.
Dijkstra-Tiekstra MJ; Setroikromo AC; Kraan M; Gkoumassi E; de Wildt-Eggen J
Transfusion; 2014 Dec; 54(12):3155-63. PubMed ID: 25109216
[TBL] [Abstract][Full Text] [Related]
40. The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability.
Balint B; Ivanović Z; Petakov M; Taseski J; Jovcić G; Stojanović N; Milenković P
Bone Marrow Transplant; 1999 Mar; 23(6):613-9. PubMed ID: 10217193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
